| Literature DB >> 11056313 |
P L Carmichael1, J C Pole, P Neven.
Abstract
Transforming growth factor beta (TGFbeta) immunoreactivity was determined in endometria from non-drug-therapy and tamoxifen-treated patients. Sections were scored for pathology and quantity image analysis performed to determine levels of glandular- or fibrosis-associated TGFbeta1. Tamoxifen-treated patients displayed greater levels of endometrial dysplasia and glandular hyperplasia, in addition to a statistically significant (P<0.0001) elevation in gland-associated TGFbeta1 protein.Entities:
Mesh：
Substances：
Year: 2000 PMID： 11056313 DOI： 10.1016/s0959-8049(00)00220-3
Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162